Search results
Found 9279 matches for
New therapeutic targets identified to treat inflammatory bowel disease
Publication
22 October 2021
Millions of patients with ulcerative colitis or Crohn’s disease, collectively known as inflammatory bowel disease (IBD), are given fresh hope as a new study shows why some of them do not respond to current treatments.
Oxford-Bristol Myers Squibb Fellowships awarded to NDORMS researchers
Awards
18 October 2021
Researchers from the Kennedy Institute of Rheumatology have been awarded fellowships as part of the Oxford-Bristol Myers Squibb Fellowship Programme. Among six researchers from across NDORMS, the programme provides them with an opportunity to gain exposure to the field of commercial drug discovery and development.
Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age
oacentre
15 October 2021
A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.
Novo Nordisk Postdoctoral Research Fellowship awarded to Inhye Park
Funding
6 October 2021
Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.
The Kennedy Institute Student Symposium returns for its 5th year
Department General
30 September 2021
A two-day student symposium returned to the Kennedy Institute bringing together students and peers from across the department to discuss their latest research.
Researchers from the Kennedy Institute awarded MRC funding
Funding General
29 September 2021
Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.
New Associate Professors announced at NDORMS
Awards
17 September 2021
The Medical Sciences Division has awarded the title of Associate Professor to five senior researchers at NDORMS
The Kennedy Institute completes its roof extension
Department General
17 August 2021
Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.
Unlocking the secrets of the microbiome
16 August 2021
Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Studies explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.
Into the future: watching biology unfold
6 August 2021
As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.
Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells
26 July 2021
Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.
Researchers show the role of cilia in cartilage health
15 July 2021
New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.
Exploring the link between joint injury and osteoarthritis
oacentre
25 June 2021
A new study published in The Lancet Rheumatology shows potential ways to predict how likely someone is to develop osteoarthritis after a knee injury.
Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship
Awards
21 June 2021
Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.
New research identifies a role for CD200 in limiting atherosclerosis
10 June 2021
A new study published in Circulation Research by researchers at the Kennedy Institute shows that CD200, an inhibitory immune checkpoint, reduces the development of atherosclerosis.
EPSRC funds research to avert an antibiotics apocalypse
Department Funding
7 June 2021
Researchers at the Kennedy Institute join a collaboration to find new ‘drug-free’ ways of treating illnesses where current treatments have become ineffective due to antibiotic resistance.
Repurposed drug can induce remission of inflammatory arthritis
20 May 2021
Researchers at the Kennedy Institute demonstrate that the drug decitabine can boost regulatory T cell responses.
NDORMS researchers awarded ECTS prizes
Awards
18 May 2021
Professor Anjali Kusumbe and Professor Cyrus Cooper have been presented with research awards by the European Calcified Tissue Society (ECTS).
Professor Katja Simon elected to the Academy of Medical Sciences
Awards
12 May 2021
Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.
Major ERC funding awarded to Professor Michael Dustin
Funding General
4 May 2021
Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.